General Biologicals Corporation (TPEX:4117)
8.36
-0.13 (-1.53%)
Sep 30, 2026, 1:50 PM CST
| Market Cap | 601.02M -37.5% |
| Revenue (ttm) | 260.23M +3.5% |
| Net Income | 518.98M |
| EPS | 7.64 |
| Shares Out | 70.79M |
| PE Ratio | 1.11 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 43,256 |
| Open | 8.50 |
| Previous Close | 8.49 |
| Day's Range | 8.36 - 8.90 |
| 52-Week Range | 3.50 - 17.30 |
| Beta | 0.57 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |